Protective role of melatonin and coenzyme Q10 in ochratoxin A toxicity in rat liver and kidney

International Journal of Toxicology

Volumn 26, Issue 1, 2007, Pages 81-87

  Sutken, Emine ^a   Aral, Erinc ^a   Ozdemir, Filiz ^b   Uslu, Sema ^a   Alatas, Ozkan ^a   Colak, Omer ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^b ANADOLU UNIVERSITY   (Turkey)

Author keywords

Coenzyme Q10; Free Radicals; Hydroxyproline; Melatonin; Ochratoxin A

Indexed keywords

GLUTATHIONE PEROXIDASE; HYDROXYPROLINE; MALONALDEHYDE; MELATONIN; OCHRATOXIN; UBIDECARENONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; KIDNEY FIBROSIS; KIDNEY HOMOGENATE; LIVER FIBROSIS; LIVER HOMOGENATE; LIVER PROTECTION; LIVER TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; RENAL PROTECTION; TISSUE LEVEL; TREATMENT DURATION;

ANIMALS; ANTIOXIDANTS; GLUTATHIONE PEROXIDASE; HYDROXYPROLINE; KIDNEY; LIVER; MALE; MALONDIALDEHYDE; MELATONIN; OCHRATOXINS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; UBIQUINONE;

RATTUS;

EID: 33847665561     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810601122893     Document Type: Article

References (44)

1. Abdel-Wahhab, M. A., M. M. Abdel-Galil, and M. El-Lithey. 2005. Melatonin counteracts oxidative stress in rats fed an ochratoxin A contaminated diet. J. Pineal Res. 38:130-135.
2. Allegra, M., R. J. Reiter, D. X. Tan., C. Gentile, L. Tesoriere, and M. A. Livrea. 2003. The chemistry of melatonin's interaction with reactive species. J. Pineal Res. 34:1-10.
3. Atroshi, F., A. Rizzo, S. Sankari, I. Biese, T. Westermarck, and P. Veijalainen. 2000. Liver enzyme activities of rats exposed to ochratoxin A and T-2 toxin with antioxidants. Bull. Environ. Contam. Toxicol. 64:586-592.
4. Aukema, H. M., J. D. House, N. Bankovic-Calic, and M. R. Ogborn. 2004. Increased renal fibrosis and expression of renal phosphatidylinositol 4-kinase-beta and phospholipase C(gamma1) proteins in piglets exposed to ochratoxin-A. Nephron Physiol. 96:19-25.
5. Baudrimont, I., A. M. Betbeder, A. Gharbi, A. Pfohl-Leszkowicz, G. Dirheimer, and E. E. Creppy. 1994. Effect of superoxide dismutase and catalase on the nephrotoxicity induced by subchronical administration of ochratoxin A in rats. Toxicology 89:101-111.
6. Bergman, I., and R. Loxley. 1969. Lung tissue hydrolysates: studies of the optimum conditions for the spectrophotometric determination of hydroxyproline. Analyst 94:575-584.
7. Bergman, I., and R. Loxley. 1970. The determination of hydroxyproline in urine hydrolysates. Clin. Chim. Acta 27:347-349.
8. Castegnaro, M., I. N. Chernozemsky, E. Hietanen, and H. Bartsch. 1990. Are mycotoxins risk factors for endemic nephropathy and associated urothelial cancers? Arch. Geschwulstforsch. 60:295-303. Review.
9. Crane, F. L. 2001. Biochemical functions of coenzyme Q10. J. Am. Coll. Nutr. 20:591-598. Review.
10. Creppy, E. E., I. Baudrimont, and A. M. Betbeder. 1995. Prevention of nephrotoxicity of ochratoxin A, a food contaminant. Toxicol. Lett. 82-83:869-877. Review.
11. Cuzzocrea, S., and R. J. Reiter. 2001. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur. J. Pharmacol. 24:426(1-2):1-10. Review.
12. Dallner, G., and P. J. Sindelar. 2000. Regulation of ubiquinone metabolism. Free Radic. Biol. Med. 29:285-294.
13. El-Sokkary, G. H., G. H. Abdel-Rahman, and E. S. Kamel. 2005. Melatonin protects against lead-induced hepatic and renal toxicity in male rats. Toxicology 15:213(25-30):25-33.
14. Farswan, M., S. P. Rathod, A. B. Upaganlawar, and A. Semwal. 2005. Protective effect of coenzyme Q10 in simvastatin and gemfibrozil induced rhabdomyolysis in rats. Indian J. Exp. Biol. 43:845-848.
15. Frei, B., M. C. Kim, and B. N. Ames. 1990. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc. Natl. Acad. Sci. U.S.A. 87:4879-4883.
16. Genova, M. L., E. Bonacorsi, M. D'Aurelio, G. Formiggini, B. Nardo, S. Cuccomarino, P. Turi, M. M. Pich, G. Lenaz, and C. Bovina. 1999. Protective effect of exogenous coenzyme Q in rats subjected to partial hepatic ischemia and reperfusion. Biofactors 9(2-4):345-349.
17. Kehrer, J. P. 1993. Free radicals as mediators of tissue injury and disease. Crit. Rev. Toxicol. 23:21-48. Review.
18. Klahr, S., and J. Morrissey. 2002. Obstructive nephropathy and renal fibrosis. Am. J. Physiol. Renal Physiol. 283:861-875.
19. Klahr, S., and J. Morrissey. 2003. Obstructive nephropathy and renal fibrosis: The role of bone morphogenic protein-7 and hepatocyte growth factor. Kidney Int. Suppl. 87:105-112.
20. Li, S., R. R. Marquardt, and A. A. Frohlich. 2000. Identification of ochratoxins and some of their metabolites in bile and urine of rats. Food Chem. Toxicol. 38:141-152.
21. Lopez-Burillo, S., D. X. Tan, J. C. Mayo, R. M. Sainz, L. C. Manchester, and R. J. Reiter. 2003. Melatonin, xanthurenic acid, resveratrol, EGCG, vitamin C and alpha-lipoic acid differentially reduce oxidative DNA damage induced by Fenton reagents: A study of their individual and synergistic actions. J. Pineal Res. 34:269-277.
22. Marquardt, R. R., and A. A. Frohlich. 1992. A review of recent advances in understanding ochratoxicosis. J. Anim. Sci. 70:3968-3988.
23. Meki, A. R., and A. A. Hussein. 2001. Melatonin reduces oxidative stress induced by ochratoxin A in rat liver and kidney. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 130:305-313.
24. Melchiorri, D., R. J. Reiter, A. M. Attia, M. Hara, A. Burgos, and G. Nistico. 1995. Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci. 56:83-89.
25. Navarro, F., A. Arroyo, S. F. Martin, R. I. Bello, R. de Cabo, J. R. Burgess, P. Navas, and J. M. Villalba. 1999. Protective role of ubiquinone in vitamin E and selenium-deficient plasma membranes. Biofactors 9(2-4):163-170.
26. Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:351-358.
27. Ohta, Y., M. Kongo, E. Sasaki, K. Nishida, and I. Ishiguro. 2000. Therapeutic effect of melatonin on carbon tetrachloride-induced acute liver injury in rats. J. Pineal Res. 28:119-126.
28. Okutan, H., G. Aydin, and N. Ozcelik. 2004. Protective role of melatonin in ochratoxin a toxicity in rat heart and lung. J. Appl. Toxicol. 24:505-512.
29. Omar,R. F., A. D. Rahimtula, and H. Bartsch. 1991. Role of cytochrome P-450 in ochratoxin A-stimulated lipid peroxidation. J. Biochem. Toxicol. 6:203-209.
30. Oz, E., and M. N. Ilhan. 2006. Effects of melatonin in reducing the toxic effects of doxorubicin. Mol. Cell Biochem. 286:11-15.
31. Paglia, D. E., andW. N. Valentine. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70:158-169.
32. Pfohl-Leszkowicz, A., T. Petkova-Bocharova, I. N. Chernozemsky, and M. Castegnaro. 2002. Balkan endemic nephropathy and associated urinary tract tumours:Areviewon aetiological causes and the potential role of mycotoxins. Food Addit. Contam. 19:282-302.
33. Portakal, O., and M. E. Inal. 1999. Effects of pentoxifylline and coenzyme Q10 in hepatic ischemia/reperfusion injury. Clin. Biochem. 32:461-466.
34. Prasad, K., and J. Karla. 1993. Oxygen free radicals and hypercholesterolemic. Atherosclerosis: Effect of vitamin E. Am. Heart J. 125:958-973.
35. Reiter, R. J. 2003. Melatonin: Clinical relevance. Best Pract. Res. Clin. Endocrinol. Metab. 17:273-285.
36. Reiter, R. J., D. X. Tan, L. C. Manchester, and W. Qi. 2001. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: A review of the evidence. Cell Biochem. Biophys. 34:237-256. Review.
37. Serdaroglu, I., K. Islamoglu, and E. Ozgentas. 2005. Effects of insulin-dependent diabetes mellitus on perforator-based flaps in streptozotocin diabetic rats. J. Reconstr. Microsurg. 21:51-56.
38. Smith-Kielland, A., J. Aaseth, and Y. Thomassen. 1986. Effect of long-term ethanol intake on the content of selenium in rat liver: Relation to the rate of hepatic protein synthesis. Acta Pharmacol. Toxicol. 58:237-239.
39. Soyoz, M., N. Ozcelik, I. Kilinc, and I. Altuntas. 2004. The effects of ochratoxin A on lipid peroxidation and antioxidant enzymes: A protective role of melatonin. Cell Biol. Toxicol. 20:213-219.
40. Tan, D. X., R. J. Reiter, L. C. Manchester, M. T. Yan, M. El-Sawi, R. M. Sainz, J. C. Mayo, R. Kohen, M. Allegra, and R. Hardeland. 2002. Chemical and physical properties and potential mechanisms: Melatonin as a broad spectrum antioxidant and free radical scavenger. Curr. Top. Med. Chem. 2:181-197. Review.
41. Upaganlawar, A., M, Farswan, S. Rathod, and R, Balaraman. 2006. Modification of biochemical parameters of gentamicin nephrotoxicity by coenzyme Q10 and green tea in rats. Indian J. Exp. Biol. 44:416-418.
42. Van der Merwe, K. J., P. S. Steyn, L. Fourie, D. B. Scott, and J. J. Theron. 1965. Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh. Nature 205:1112-1113.
43. Van Ginkel, G., and A. Sevanian. 1994. Lipid peroxidation-induced membrane structural alterations. Methods Enzymol. 233:273-288.
44. Zang, L. Y., G. Comsa, H. Gardner, and V. Vallyathan. 1998. Scavenging of reactive oxygen species by melatonin. Biochim. Biophys. Acta 27:1425:469-477.